Thomas J. Flotte

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• 3 Cardiac SARS-CoV-2 Viral Persistence in Decedents with Long COVID Manifesting Cardiac Symptoms: A Multi-Institutional Study from the RECOVER Program Autopsy Cohort

  Laboratory Investigation · 2026-03-01

• ASO Visual Abstract: Accuracy of PET–CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment

  Annals of Surgical Oncology · 2025-09-16

• Accuracy of PET–CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment

  Annals of Surgical Oncology · 2025-08-26 · 1 citations

• NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma

  European Journal of Cancer · 2025-08-06 · 4 citations

• NeoACTIVATE arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable stage III melanoma.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial

  Journal for ImmunoTherapy of Cancer · 2025-04-01 · 8 citations

• 1125P Accuracy of PET-CT to assess extent of nodal disease in clinical stage III melanoma

  Annals of Oncology · 2024-09-01 · 1 citations